Koers BriaCell Therapeutics Corp. Nasdaq
Aandelen
BCTX
CA1079301091
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,17 USD | -3,12% | +7,43% | -62,91% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 34,21 mln. 31,99 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -24 mln. -22,45 mln. | Nettowinst (verlies) 2025 * | -28 mln. -26,19 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,54
x | K/w-verhouding 2025 * |
-1,71
x | Werknemers | 16 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 87,73% |
1 dag | -3,13% | ||
1 week | +7,43% | ||
Lopende maand | -24,13% | ||
1 maand | -18,73% | ||
3 maanden | -45,75% | ||
6 maanden | -42,74% | ||
Lopend jaar | -62,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01-11-16 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01-02-16 |
Chief Tech/Sci/R&D Officer | 53 | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10-05-16 |
Marc Lustig
BRD | Director/Board Member | 51 | 31-08-21 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07-03-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 2,17 | -3,13% | 36 051 |
25-04-24 | 2,24 | +2,28% | 29 085 |
24-04-24 | 2,19 | -5,60% | 22 628 |
23-04-24 | 2,32 | +5,45% | 36 120 |
22-04-24 | 2,2 | +8,91% | 17 379 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |